OnKure Therapeutics, Inc.

Ownership Transactions Reported by 28 Insiders

Symbol
OKUR on Nasdaq
Industry
Pharmaceutical Preparations
Location
6707 Winchester Circle, Suite 400, Boulder, CO

Insiders trading volume in the past year

OnKure Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novo Holdings A/S 10%+ Owner $20.9M Jun 23, 2023
Gregory J. Flesher President and CEO, Director $723K Dec 9, 2022
Braden Michael Leonard Former 10% owner of RPHM $670K +$1.73M Oct 7, 2024
Michael Cruse Chief Operating Officer $310K Dec 9, 2022
Ashley Hall Chief Development Officer $249K Aug 28, 2023
Vineet R. Jindal Chief Financial Officer $230K Dec 10, 2021
Alejandro Dorenbaum Chief Medical Officer $188K Dec 9, 2022
Jennifer Lam VP of Finance & Administration $129K Dec 9, 2022
Nicholas A. Saccomano President and CEO, Director Oct 4, 2024
Samuel Agresta Chief Medical Officer Oct 4, 2024
Cormorant Asset Management, LP 10%+ Owner Oct 4, 2024
Edward T. Mathers Director Oct 4, 2024
Michael G. Grey Director Oct 4, 2024
Wendy S. Johnson Chief Development Officer Jul 14, 2021
Eric M. Dube Director Jun 6, 2023
Paul W. Hoelscher Director Jun 6, 2023
Stacey Denenberg Seltzer Director Jun 6, 2023
Niall O'Donnell Director Jun 6, 2023
Roshawn A. Blunt Director Jun 6, 2023
Kenneth Ph.D. Harrison Director Apr 8, 2021
Bali Muralidhar Director Jun 6, 2023
R. Michael Carruthers Director Oct 4, 2024
Dylan Hartley Chief Scientific Officer Oct 4, 2024
Acorn Bioventures, L.P. 10%+ Owner Oct 4, 2024
Valerie Malyvanh Jansen Director Oct 4, 2024
Jason A. Leverone Chief Financial Officer Oct 4, 2024
Isaac Manke Director Oct 4, 2024
Andrew John Phillips Director Oct 4, 2024

Recent Insider Transactions by Companies or Individuals for OnKure Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.